Tie-Ning Zhang

TL;DR: The evidence suggests a generally small risk of congenital malformations and argues against a substantial teratogenic effect of SSRIs and Caution is advisable in making decisions about whether to continue or stop treatment withSSRIs during pregnancy.

TL;DR: Non-coding RNAs provide a new insight into sepsis and could become the novel therapeutic targets in the future to further understanding of the disease process.

TL;DR: Transmission electron microscopy demonstrated that autophagy was enhanced in the ovarian tissue from both humans and rats with PCOS, and ovarian granulosa cells from PCOS rats showed increases in the Autophagy marker protein light chain 3B (LC3B), whereas levels of the autophile substrate SQSTM1/p62 were decreased.

TL;DR: The results of this meta-analysis indicate maternal fluoxetine use is associated with a slightly increased risk of cardiovascular malformations in infants, and health care providers and pregnant women must weigh the risk-benefit potential of these drugs when making decisions about whether to treat with fluoxettine during pregnancy.

TL;DR: This meta‐analysis suggested that the use of sertraline use by pregnant women in the first trimester had an increased risk of cardiovascular‐related malformations as well as atrial and/or ventricular septal defects in infants.